The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

被引：0
|
作者：
Frank Wiesmann
Jan Vachta
Robert Ehret
Hauke Walter
Rolf Kaiser
Martin Stürmer
André Tappe
Martin Däumer
Thomas Berg
Gudrun Naeth
Patrick Braun
Heribert Knechten
机构：
[1] PZB Aachen,HIV&Hepatitis Research Group
[2] University of Erlangen,Roche Pharma
[3] Institute for Clinical and Molecular Virology,Laboratories Thiele
[4] Schloßgarten,Medical Laboratories Berg
[5] University of Cologne,undefined
[6] Institute for Virology,undefined
[7] University of Frankfurt,undefined
[8] Institute for Virology,undefined
[9] Clinical Project Management,undefined
[10] Institute for Immunology and Genetics,undefined
[11] HIV Research,undefined
来源：
AIDS Research and Therapy | / 8卷
关键词：
Saquinavir; Atazanavir; Lopinavir; Amprenavir; Darunavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
    Wiesmann, Frank
    Vachta, Jan
    Ehret, Robert
    Walter, Hauke
    Kaiser, Rolf
    Stuermer, Martin
    Tappe, Andre
    Daeumer, Martin
    Berg, Thomas
    Naeth, Gudrun
    Braun, Patrick
    Knechten, Heribert
    AIDS RESEARCH AND THERAPY, 2011, 8
  • [2] Prevalence, Mutation Patterns, and Effects on Protease Inhibitor Susceptibility of the L76V Mutation in HIV-1 Protease
    Young, Thomas P.
    Parkin, Neil T.
    Stawiski, Eric
    Pilot-Matias, Tami
    Trinh, Roger
    Kempf, Dale J.
    Norton, Michael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (11) : 4903 - 4906
  • [3] Molecular mechanisms of HIV-1 protease resistance and resensitization towards lopinavir and saquinavir upon L76V mutation
    Bastys, T.
    Doncheva, N. T.
    Walter, H.
    Kaiser, R.
    Albrecht, M.
    Kalinina, O. V.
    ANTIVIRAL THERAPY, 2014, 19 : A154 - A154
  • [4] Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance
    de Mendoza, Carmen
    Garrido, Carolina
    Corral, Angelica
    Zahonero, Natalia
    Soriano, Vincent
    AIDS, 2008, 22 (02) : 311 - 313
  • [5] Susceptibility to saquinavir and atazanavir in highly protease inhibitor (PI) resistant HIV-1 is caused by lopinavir-induced drug resistance mutation L76V
    Mueller, SM
    Daeumer, M
    Kaiser, R
    Walter, H
    Colonno, R
    Korn, K
    ANTIVIRAL THERAPY, 2004, 9 (04) : U44 - U45
  • [6] Clinically relevant resensitization of protease inhibitors (PIs) saquinavir and atazanavir (ATV) by L76V mutation in multidirug-resistant HIV-1-infected patients
    Braun, P.
    Walter, H.
    Hoffmann, D.
    Daeumer, M.
    Ehret, R.
    Korn, K.
    Thiele, B.
    Berg, T.
    Stuermer, M.
    Wiesmann, F.
    Kaiser, R.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S142 - S142
  • [7] Clinically relevant resensitization of protease inhibitors (PIs) saquinavir and atazanavir (ATV) by L76V mutation in multidrug-resistant HTV-1-infected patients
    Braun, P.
    Walter, H.
    Hoffmann, D.
    Daeumer, M.
    Ehret, R.
    Korn, K.
    Thiele, B.
    Berg, T.
    Stuermer, M.
    Wiesmann, F.
    Kaiser, R.
    ANTIVIRAL THERAPY, 2007, 12 : S142 - S142
  • [8] Description of the L76V Resistance Protease Mutation in HIV-1 B and "Non-B" Subtypes
    Charpentier, Charlotte
    Lambert-Niclot, Sidonie
    Alteri, Claudia
    Storto, Alexandre
    Flandre, Philippe
    Svicher, Valentina
    Perno, Federico
    Brun-Vezinet, Francoise
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Ceccherini-Silberstein, Francesca
    Descamps, Diane
    PLOS ONE, 2013, 8 (01):
  • [9] Drug Resistance Mutation L76V Alters Nonpolar Interactions at the Flap-Core Interface of HIV-1 Protease
    Wong-Sam, Andres
    Wang, Yuan-Fang
    Zhang, Ying
    Ghosh, Arun K.
    Harrison, Robert W.
    Weber, Irene T.
    ACS OMEGA, 2018, 3 (09): : 12132 - 12140
  • [10] Factors associated with the L76V protease mutation in HIV-1-infected patients with virological failure of lopinavir/ritonavir
    Baras, A.
    Champenois, K.
    Choisy, P.
    Yazdanpanah, Y.
    Bocket, L.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A114 - A114
12345